Kiker Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-210
Closed -$9.72K 285
2025
Q2
$9.72K Sell
210
-5,420
-96% -$266K 0.01% 363
2025
Q1
$343K Sell
5,630
-444
-7% -$25.9K 0.23% 73
2024
Q4
$344K Buy
+6,074
New +$339K 0.28% 71

Other funds holding BMY

Kiker Wealth Management's BMY Position: Q3 2025 in Review

Kiker Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 210 shares — an estimated $9.72K sold.

Kiker Wealth Management first reported a position in BMY in Q4 2024 and held it in 3 quarters. The position peaked at $344K in Q4 2024. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Kiker Wealth Management reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • Kiker Wealth Management sold 210 Bristol-Myers Squibb shares in Q3 2025, an estimated $9.72K.
  • Kiker Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 3 quarters.
  • Kiker Wealth Management's Bristol-Myers Squibb position peaked at $344K in Q4 2024.
  • 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Kiker Wealth Management's 13F filing for Q3 2025, filed 27 Oct 2025.